Myriad Genetics stock hits 52-week low at $12.16 amid market challenges
Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...
manilatimes5h
Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and ...
Scientific American2d
How Neandertal DNA May Affect the Way We Think
Comparison of that ancient DNA with modern human DNA showed that the two species had interbred and that people today still ...
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online ...
News Medical8d
At-Home Test Kits: How They Work and What They Can Detect
At-home test kits offer a convenient way to monitor health conditions privately, using advanced technologies for accurate and ...
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance
As set forth above, the company’s financial results for the quarter and full year ended December 31, 2024 set forth in this press release are preliminary and subject to Myriad Genetics’ normal quarter ...
Mena FN14d
Myriad Genetics Signs Agreement With Nationally Renowned Sports Broadcaster Hannah Storm To Promote The Importance Of Knowing Family Cancer History
(MENAFN- GlobeNewsWire - Nasdaq) SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement ...
Yahoo Finance14d
UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, President and CEO, and Sam ...
Santé log14d
UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
News release updated to include the members of the management team speaking at the conference. SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in ...
Nature16d
Myriad and the mass media: the covering of a gene patent controversy
Results: Myriad Genetic's BRCA1/2 gene patents sparked ... threat of patent infringement action against government testing laboratories and potential impacts on public health care.
EurekAlert!16d
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
HOUSTON and SALT LAKE CITY ― The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and ...
verywellhealth16d
What Is the Genetic Theory of Aging?
Your DNA may predict more about you than the way you look. According to the genetic theory of aging, your genes (as well as mutations in those genes) are responsible for how long you'll live. Here's ...